These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25384808)

  • 1. Severe colitis caused by biologics: what an endoscopist needs to know.
    Ratuapli SK; Depetris G; Shepard B; Nguyen CC
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):287-90. PubMed ID: 25384808
    [No Abstract]   [Full Text] [Related]  

  • 2. The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.
    Yamauchi R; Araki T; Mitsuyama K; Tokito T; Ishii H; Yoshioka S; Kuwaki K; Mori A; Yoshimura T; Tsuruta O; Torimura T
    BMC Gastroenterol; 2018 Aug; 18(1):135. PubMed ID: 30170560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Education and imaging. Gastrointestinal: severe inflammatory bowel disease-associated pyoderma gangrenosum.
    Freedberg DE; Husain S; Swaminath A
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1691. PubMed ID: 24147454
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of severe attack of ulcerative colitis].
    Tysk C; Almer S; Andersson MV; Befrits R; Hertervig E; Kilander A; Lindgren S; Suhr O
    Lakartidningen; 2009 Nov 4-12; 106(45):2994-8. PubMed ID: 19998825
    [No Abstract]   [Full Text] [Related]  

  • 5. Ipilimumab-induced colitis: a rare but serious side effect.
    Hinds AM; Ahmad DS; Muenster JE; Berg ZM; Lopez KT; Holly JS; Matteson-Kome ML; Bechtold ML
    Endoscopy; 2014; 46 Suppl 1 UCTN():E308-9. PubMed ID: 25058826
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations.
    Kosmidou M; Gaitanis G; Nomikos K; Zioga A; Katsanos K; Bassukas ID; Tsianos E
    Acta Derm Venereol; 2009; 89(5):522-3. PubMed ID: 19734983
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
    Fratila OC; Craciun C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for refractory ulcerative colitis.
    Chey WY; Hussain A; Ryan C; Potter GD; Shah A
    Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC; Prather CM
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract]   [Full Text] [Related]  

  • 10. Types of colitis based on histology.
    Sherid M; Ehrenpreis ED
    Dis Mon; 2011 Sep; 57(9):457-89. PubMed ID: 21944389
    [No Abstract]   [Full Text] [Related]  

  • 11. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.
    Baudet A; Colombel JF; Cortot A; Dupas JL; Brazier F; Savoye G; Lerebours E; Justum AM; Reimund JM
    Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
    Sandborn WJ; Rutgeerts P; Feagan BG; Reinisch W; Olson A; Johanns J; Lu J; Horgan K; Rachmilewitz D; Hanauer SB; Lichtenstein GR; de Villiers WJ; Present D; Sands BE; Colombel JF
    Gastroenterology; 2009 Oct; 137(4):1250-60; quiz 1520. PubMed ID: 19596014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to judge the response to treatment in ulcerative colitis?
    Järnerot G
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S222-3. PubMed ID: 18816742
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe acute respiratory distress syndrome due to ipilimumab.
    Franzen D; Schad K; Dummer R; Russi EW
    Eur Respir J; 2013 Sep; 42(3):866-8. PubMed ID: 24000256
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of infliximab in patients suffering from inflammatory bowel disease.
    Felley C; Michetti P
    Digestion; 2004; 70(1):1-2. PubMed ID: 15297772
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
    Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
    Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis.
    Veerappan SG; O'Morain CA
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):830-2. PubMed ID: 19398919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
    Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab in severe steroid-refractory ulcerative colitis: a pilot study.
    Kaser A; Mairinger T; Vogel W; Tilg H
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):930-3. PubMed ID: 11802508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.